Who We Are and What We Do
At GlycoMimetics, we are committed to helping make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments.
GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Based on that technology, we have developed a robust, diversified product pipeline.
We are a public company, traded on the NASDAQ under the symbol GLYC. We are located in Rockville, Maryland in the BioHealth Capital Region.Learn more.